Medicamen Biotech informs about disclosure

08 Mar 2024 Evaluate
Medicamen Biotech has informed that it attached disclosure dated March 08, 2024 in Form-D pursuant to Regulation 7(3) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 with respect to intimation received from Geetika Madan, immediate relative of Rajesh Madan, Chief Executive Officer for sale of 5531 Equity Shares from the open market. This intimation is in compliance with Regulation 7(3) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Medicamen Biotech Share Price

381.90 -8.35 (-2.14%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×